Ben Tre Pharmaceutical JSC (HOSE: DBT)

Market Cap	232.63B
Revenue (ttm)	828.64B
Net Income (ttm)	16.89B
Shares Out	18.61M
EPS (ttm)	948.29
PE Ratio	13.18
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	900
Open	13,050
Previous Close	13,100
Day's Range	12,850 - 13,050
52-Week Range	9,737 - 14,100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant...

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 566
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBT

Financial Performance

In 2019, DBT's revenue was 800.50 billion, a decrease of -1.16% compared to the previous year's 809.91 billion. Earnings were 21.40 billion, an increase of 5.95%.